Table 1.
Postoperative atrial arrhythmia
Characteristics | No postoperative AA n = 220 |
With postoperative AA n = 73 |
Univariable OR (95%CI) |
p-value | Multivariable OR(95%CI) |
p-value |
---|---|---|---|---|---|---|
Age(year) | 56±14 | 60±10 | 1.03 (1.01,1.06) | 0.007 | 1.03 (1.00,1.07) | 0.061 |
Male gender | 114 (51.8) | 54 (74.0) | 2.64 (1.47,4.75) | 0.001 | 1.97 (0.95,4.09) | 0.069 |
BMI(kg/m2) | 25.1±5.6 | 26.7±5.2 | 1.05 (1.00,1.10) | 0.040 | 1.05 (0.98,1.13) | 0.174 |
Pulmonary pathology | ||||||
Group A; obstructive | 60 (27.3) | 17 (23.3) | 1.00 (Reference) | - | - | - |
Group B; vascular | 5 (2.3) | 1 (1.4) | 0.71 (0.08,6.46) | 0.758 | - | - |
Group C; immunologic | 17 (7.7) | 4 (5.5) | 0.83 (0.25,2.80) | 0.764 | - | - |
Group D; restrictive | 138 (62.7) | 51 (69.9) | 1.30 (0.70,2.44) | 0.406 | - | - |
Preoperative O2 support (lpm) | 4 (3–6) | 4 (3–6) | 0.98 (0.93,1.04) | 0.507 | - | - |
Ventilator/ECMO | 6 (2.7) | 1 (1.4) | 0.50 (0.06,4.18) | 0.519 | - | - |
History of CAD | 88 (40.0) | 33 (45.2) | 1.20 (0.68,2.11) | 0.534 | - | - |
History of hypertension | 116 (52.7) | 42 (57.9) | 1.22 (0.71,2.07) | 0.476 | - | - |
History of diabetes mellitus | 69 (31.4) | 17 (23.3) | 0.66 (0.36,1.23) | 0.191 | 0.48 (0.22,1.07) | 0.074 |
History of dyslipidemia | 86 (39.1) | 37 (50.7) | 1.60 (0.94,2.73) | 0.083 | 1.58 (0.43,5.79) | 0.491 |
History of smoking | 88 (40.0) | 33 (45.2) | 1.24 (0.73,2.11) | 0.434 | - | - |
History of stroke | 4 (1.8) | 1 (1.4) | 0.75 (0.08,6.82) | 0.798 | - | - |
CHADS2 score | 1 (0–1) | 1 (0–1) | 0.80 (0.47,1.38) | 0.429 | - | - |
Serum creatinine (mg/dl) | 0.8±0.3 | 0.8±0.3 | 1.20 (0.43,3.35) | 0.726 | - | - |
Cardiovascular medications | ||||||
Statins | 76 (34.5) | 31 (42.5) | 1.40 (0.81,2.40) | 0.224 | 0.83 (0.24,3.31) | 0.866 |
Aspirin | 50 (22.7) | 20 (27.4) | 1.28 (0.70,2.35) | 0.418 | - | - |
Beta blockers | 40 (18.2) | 13 (17.8) | 0.98 (0.49,1.95) | 0.943 | - | - |
ACEI | 28 (12.7) | 11 (15.1) | 1.22 (0.57,2.59) | 0.610 | - | - |
ARB | 21 (9.5) | 7 (9.6) | 1.01 (0.41,2.47) | 0.991 | - | - |
Calcium channel blockers | 36 (16.4) | 13 (17.8) | 1.11 (0.55,2.23) | 0.774 | - | - |
Diuretics | 68 (30.9) | 18 (24.7) | 0.73 (0.40,1.34) | 0.311 | - | - |
Echocardiographic data | ||||||
LVEF (%) | 60±6 | 60±5 | 1.00 (0.96,1.05) | 0.873 | ||
LVEDD (cm) | 4.1±0.6 | 4.4±0.5 | 1.91 (1.16,3.15) | 0.011 | 1.37 (0.75,2.50) | 0.307 |
IVSD (cm) | 1.00±0.89 | 0.92±0.36 | 0.83 (0.50,1.39) | 0.479 | - | - |
LAV (cm) | 40±19 | 43±21 | 1.01 (0.99,1.03) | 0.315 | - | - |
LAA (cm2) | 16±10 | 16±5 | 1.00 (0.97,1.04) | 0.929 | - | - |
Right heart catheterization data | ||||||
mPAP (kPa) | 3.47±1.33 (26±10 mmHg) | 3.20±1.07 (24±8 mmHg) | 0.97 (0.93,1.00) | 0.042 | 0.95 (0.91,0.99) | 0.027 |
Pulmonary hypertension | 88 (43.6) | 18 (28.6) | 0.52 (0.28,0.96) | 0.036 | - | - |
PCWP (kPa) | 1.33±0.67 (10±5 mmHg) | 1.33±0.67 (10±5 mmHg) | 1.00 (0.94,1.06) | 0.900 | - | - |
Double lung transplant | 130 (59.4) | 53 (72.6) | 1.81 (1.02,3.24) | 0.044 | 2.79 (1.36,5.75) | 0.005 |
Lung allocation score | 38.2 (33.6–45.0) | 37.5 (34.5–43.8) | 1.00 (0.99,1.02) | 0.765 | ||
Ischemic time(minute) | 202±68 | 217±61 | 1.00 (1.00,1.01) | 0.096 | 1.00 (0.99,1.01) | 0.732 |
Peak troponin (mg/dl) | 6.2 (3.5–12.5) | 8.6 (3.6–15.1) | 1.00 (1.00,1.01) | 0.509 | - | - |
Vasopressor use | 179 (81.4) | 68 (93.2) | 3.12 (1.18,8.21) | 0.022 | 1.81 (0.55,5.98) | 0.329 |